TherapeuticsMD (TXMD) Gross Margin (2011 - 2023)
TherapeuticsMD (TXMD) reported Gross Margin of 100.00% for Q4 2023, unchanged from 100.00% a year earlier and up 200.00 percentage points from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Gross Margin (2011 - 2023) Analysis & Trends
Dating back to Q1 2011, TherapeuticsMD's Gross Margin record includes 50 quarters.
- Gross Margin has a five-year change of +17.00 percentage points (FY2018 to FY2023).
- By year, Gross Margin came in at 98.00% in FY2022 (+52.49 pp), 45.51% in FY2021 (-29.86 pp), 75.37% in FY2020 (-11.87 pp) and 87.24% in FY2019 (+4.24 pp).
- Five-year quarterly Gross Margin spans a low of -100.00% in Q3 2023 and a high of 2082.45% in Q1 2022.
- Year over year, Gross Margin gained in two of the last four quarters, with an average year-over-year change of +12.24 percentage points.
- The high point for year-over-year Gross Margin in five years was Q1 2022 (a gain of 2006.04 percentage points); the low point was Q1 2023 (a drop of 1982.45 percentage points).
- Per Business Quant data, the three quarters before Q4 2023 came in at -100.00% (Q3 2023), 100.00% (Q2 2023) and 100.00% (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 72.78% |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 100.00% |
| Sep 30, 2023 | -100.00% |
| Jun 30, 2023 | 100.00% |
| Mar 31, 2023 | 100.00% |
| Dec 31, 2022 | 100.00% |
| Mar 31, 2022 | 2,082.45% |
| Dec 31, 2021 | 74.64% |
| Sep 30, 2021 | 79.21% |
| Jun 30, 2021 | 82.04% |
| Mar 31, 2021 | 76.41% |
| Dec 31, 2020 | 75.28% |
| Sep 30, 2020 | 83.05% |
| Jun 30, 2020 | 58.88% |
| Mar 31, 2020 | 77.84% |
| Dec 31, 2019 | 81.90% |
| Sep 30, 2019 | 93.91% |
| Jun 30, 2019 | 79.45% |
| Mar 31, 2019 | 80.67% |
| Dec 31, 2018 | 81.33% |
| Sep 30, 2018 | 79.88% |
API Access
TherapeuticsMD Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();